Epirubicin inhibits DNA and RNA synthesis by intercalating DNA strands [7] and Topotecan inhibits cancer cell differentiation through PPARγ degradation [12], which disturbs the normal processes of cell division and differentiation, and impedes cell damage repair,. Here, PPARG is linked to cancer.